Markt für Strahlungsdosismanagement – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPHE100001217
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 206
Buy Now

Der Markt für Strahlendosismanagement soll bis 2028 646,87 Millionen US-Dollar erreichen, von 270,32 Millionen US-Dollar im Jahr 2021; es wird geschätzt, dass es zwischen 2021 und 2028 um 13,3 % CAGR wachsen wird.



Die Strahlentherapie ist ein wesentlicher Zweig der medizinischen Wissenschaft. Verschiedene Krankheiten wie Krebs, Herz-Kreislauf-Erkrankungen usw. werden durch elektromagnetische Wellen diagnostiziert und behandelt. Es wird ausgiebig zur Behandlung verschiedener Krebsarten eingesetzt. Allerdings hat die Strahlentherapie auch Nebenwirkungen. Daher ist die Überwachung der korrekten Strahlendosis bei jedem strahlenbasierten medizinischen Verfahren äußerst wichtig. Die Strahlendosis ist die Menge an Strahlung, die auf den Patienten geworfen wird. Das Strahlendosismanagement umfasst Informationen über die Software zur Aufzeichnung der Strahlendosis; Echtzeit-Personaldosisüberwachung; Einhaltung gesetzlicher Vorschriften; und Technologien zur Dosisreduzierung, wie z Bedenken im Zusammenhang mit Strahlenbelastung und steigenden Krebsfällen, die eine Strahlentherapie erfordern. Die organisatorischen Herausforderungen und das Fehlen von Benchmarking zur Dosisoptimierung behindern jedoch das Marktwachstum.



Strategische Einblicke



Lukrative Regionen im Markt für Strahlendosismanagement



Markteinblicke



Zunehmender Fokus auf interventionelle Radiologie und Nuklearmedizin



Schnelle Fortschritte in der Medizintechnik, Geräteherstellung und Bildgebungsgeräten haben dazu geführt, dass Verfeinerung ursprünglicher Verfahren mit besseren Techniken und Erweiterung der Indikationen für Verfahren. Neue Techniken wurden entwickelt und einige Techniken wurden auf andere Bildgebungsmodalitäten übertragen. Aufgrund der hohen Bildgebungseffizienz werden weltweit vermehrt interventionelle radiologische und nuklearmedizinische Verfahren durchgeführt. Nach Angaben der Society of Nuclear Medicine werden in den USA jedes Jahr etwa 20 Millionen nuklearmedizinische Eingriffe durchgeführt. Wie von der World Nuclear Association berichtet, verwenden mehr als 10.000 Krankenhäuser weltweit Radioisotope in der Medizin, und 90 % der Radioisotopenverfahren sind diagnostisch. Marktteilnehmer wie Bayer Healthcare und Sectra Medical Systems bieten Dosismanagement-Software speziell für RDM in der interventionellen Bildgebung und Nuklearmedizin an. Daher bietet der wachsende Fokus auf die interventionelle Radiologie und Nuklearmedizin Chancen für das Wachstum des Marktes.



Service-/softwarebasierte Einblicke


Basierend auf Diensten/Software wurde der globale Markt für Strahlendosismanagement in Strahlendosismanagementdienste und Strahlendosismanagementsoftware unterteilt. Das Segment Strahlendosis-Management-Software hielt im Jahr 2021 den größten Marktanteil und wird voraussichtlich im Prognosezeitraum eine CAGR von 13,6 % auf dem Markt verzeichnen.



Strahlungsdosismanagementmarkt, nach Service/Software - 2021 und 2028



Medienbasierte Erkenntnisse



Basierend auf dem Medium ist der globale Markt für Strahlendosismanagement in Computertomographie, Bestrahlung und Mammographie, Fluoroskopie und Mammographie und andere Medien unterteilt. Das Segment Computertomographie hielt 2021 den größten Marktanteil und wird im Prognosezeitraum voraussichtlich eine CAGR von 13,8 % auf dem Markt verzeichnen.



Endnutzerbasierte Erkenntnisse< /h3>

Basierend auf dem Endbenutzer ist der Markt für Strahlendosismanagement in Krankenhäuser, Forschungs- und medizinische Institute und andere unterteilt. Das Krankenhaussegment hatte 2021 den größten Marktanteil und wird im Prognosezeitraum voraussichtlich die höchste CAGR von 13,6 % auf dem Markt verzeichnen.



Produkteinführungen und -zulassungen sind üblich angenommene Strategien von Unternehmen, um ihre globale Präsenz und ihr Produktportfolio zu erweitern. Darüber hinaus konzentrieren sich die Marktteilnehmer für Strahlendosismanagement auf die Partnerschaftsstrategie, um ihren Kundenkreis zu erweitern, was es ihnen wiederum ermöglicht, ihren Markennamen auf der ganzen Welt aufrechtzuerhalten.



Unternehmensprofile< /h3>


  1. FUJIFILM Holdings Corporation

  2. Bayer AG

  3. Bracco Imaging SpA

  4. GE Healthcare

  5. Koninklijke Philips NV

  6. Medsquare

  7. Novarad Corporation
  8. QAELUM INC

  9. Sectra AB

  10. PACSHealth, LLC



Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the key players in the radiation dose management market?

The radiation dose management market majorly consists of the players such as FUJIFILM Holdings Corporation; Bayer AG; Bracco Imaging S.p.A; GE Healthcare; Koninklijke Philips N.V.; Medsquare; Novarad Corporation; QAELUM INC; Sectra AB; PACSHealth, LLC: among others.

What is the regional market scenario of radiation dose management?

Global radiation dose management market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for radiation dose management. The market growth in the country is attributed to the factors such as the stringent legislative and accreditation requirements regarding the reporting and optimization of radiation doses, high adoption of HCIT technologies, and the presence of stringent regulatory requirements regarding patient safety. And, North America is the fastest-growing region growing at the CAGR of 13.8% during the forecast period.

Which End user held the largest share in the radiation dose management market?

The hospitals segment dominated the global radiation dose management market and accounted for the largest revenue share of 51.14% in 2021.

Which medium held the largest share in the radiation dose management market?

The Computed Tomography segment dominated the global radiation dose management market and held the largest revenue share of 42.54% in 2021.

What is radiation dose management?

Radiation dose management involves services and software that keep records of the radiation doses, real time dose monitoring, regulatory compliance. It is an information technology which is considerate in lowering the dose with integrative reconstruction software. The software assists to find the right way to radiation dose for a patient to get treated by the integration of medical technology and insightful data & services.

What are the driving factors for the radiation dose management market across the globe?

Key factors that are driving the growth of this market are growing concerns related to radiation exposure, and rising cases of cancer demanding radiation therapy.

Which service or software held the largest share in the radiation dose management market?

The Radiation Dose Management software segment dominated the global radiation dose management market and held the largest revenue share of 77.67% in 2021.

List of Companies - Radiation Dose Management Market           

  1. FUJIFILM Holdings Corporation
  2. Bayer AG
  3. Bracco Imaging S.p.A
  4. GE Healthcare
  5. Koninklijke Philips N.V.
  6. Medsquare
  7. Novarad Corporation
  8. QAELUM INC
  9. Sectra AB
  10. PACSHealth, LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports